Precigen (PGEN) Change in Acquisitions & Divestments (2013 - 2026)
Precigen's (PGEN) quarterly Change in Acquisitions & Divestments came in at $55.1 million in Q1 2026, up 1104.88% year-on-year from $4.6 million in Q1 2025, and down 13.56% on a QoQ basis from $63.7 million in Q4 2025.
Precigen (PGEN) Change in Acquisitions & Divestments (2013 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Change in Acquisitions & Divestments data on file, last reported at $55.1 million in Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 1104.88% year-over-year to $55.1 million in Q1 2026; TTM through Mar 2026 was $259.0 million, a 93.27% increase from a year earlier, with the FY2025 full-year figure at $208.5 million, up 19.11% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $55.1 million, down from $63.7 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for PGEN reached as high as $82.3 million in Q3 2025 and fell as low as $4.6 million in Q1 2025.
- Historically, Change in Acquisitions & Divestments has averaged $40.6 million across 5 years, with a median of $45.6 million in 2024.
- Across the five-year window, Change in Acquisitions & Divestments sank 89.97% in 2025 and surged 1104.88% in 2026, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $11.5 million in 2022, then surged by 297.67% to $45.6 million in 2023, then advanced by 5.24% to $48.0 million in 2024, then surged by 32.74% to $63.7 million in 2025, then dropped by 13.56% to $55.1 million in 2026.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $55.1 million in Q1 2026, $63.7 million in Q4 2025, and $82.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.10 Mn |
| Mar 31, 2026 | 55.10 Mn |
| Dec 31, 2025 | 63.74 Mn |
| Dec 31, 2025 | 63.74 Mn |
| Sep 30, 2025 | 82.27 Mn |
| Sep 30, 2025 | 82.27 Mn |
| Jun 30, 2025 | 57.88 Mn |
| Jun 30, 2025 | 57.88 Mn |
| Mar 31, 2025 | 4.57 Mn |
| Mar 31, 2025 | 4.57 Mn |
| Dec 31, 2024 | 48.02 Mn |
| Dec 31, 2024 | 48.02 Mn |
| Sep 30, 2024 | 29.66 Mn |
| Sep 30, 2024 | 29.66 Mn |
| Jun 30, 2024 | 51.75 Mn |
| Jun 30, 2024 | 51.75 Mn |
| Mar 31, 2024 | 45.58 Mn |
| Mar 31, 2024 | 45.58 Mn |
| Dec 31, 2023 | 45.63 Mn |
| Dec 31, 2023 | 45.63 Mn |